Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
202.60
Ask:
203.00
Spread: 0.40 (0.197%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jan 2017 07:00

RNS Number : 1862U
Ashmore Group PLC
16 January 2017
 

 Ashmore Group plc

+0700 16 January 2017

SECOND QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces today the following update to its assets under management ("AuM") in respect of the quarter ended 31 December 2016.

Assets under management

Theme

Actual30 September 2016

(US$ billion)

Estimated31 December 2016

(US$ billion)

Movement

Q2 vs Q1

(%)

External debt

12.2

11.4

-7%

Local currency

13.7

12.4

-9%

Corporate debt

5.3

5.2

-2%

Blended debt

14.5

14.1

-3%

Equities

3.0

2.9

-3%

Alternatives

1.5

1.5

-

Multi-asset

1.2

1.1

-8%

Overlay / liquidity

3.2

3.6

+13%

Total

54.6

52.2

-4%

 

Assets under management declined by US$2.4 billion during the period, comprising negative investment performance of US$1.7 billion and net outflows of US$0.7 billion.

Overlay and blended debt delivered net inflows over the quarter, and flows were neutral in the corporate debt, equities and alternatives themes. Net outflows were mainly experienced in local currency and external debt, and were influenced by a small number of segregated account redemptions and a reduction in mutual fund flows following the US election. The multi-asset theme saw a small net outflow during the period.

The steepening of yield curves and strengthening of the US dollar led to negative investment performance in local currency, blended debt, external debt and, to a lesser extent, in corporate debt and equities, while the other investment themes were flat in performance terms over the period. Despite lower market levels, Ashmore's investment performance relative to benchmarks remained very strong throughout the quarter across all fixed income and equities investment themes.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging Markets produced very strong investment returns in 2016 and delivered a 5% increase in Ashmore's AuM over the calendar year. This was despite the final quarter being impacted by the US election outcome, renewed strength in the US dollar, and a steepening of yield curves. While these factors interrupted the improvement in sentiment towards Emerging Markets, the effect proved to be short-lived with asset prices strengthening in December and continuing into the new year. The combination of attractive absolute and relative returns, accelerating GDP growth, and low allocations all support the expectation of further strong performance in 2017 and a return to the improving flow trend seen for most of 2016."

Notes

1. For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.2340 at 31 December 2016 (30 June 2016: 1.3234; 31 December 2015: 1.4736). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the first half of the financial year was 1.2809 (H1 2015/16: 1.5291).

Ashmore will announce its interim results in respect of the six months ended 31 December 2016 on 9 February 2017.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingAndrew Walton +44 (0)20 3727 1514Kit Dunford +44 (0)20 3727 1143

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFITLLIVLID
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.